Uncovering the genetic link between acute myocardial infarction and ulcerative colitis co-morbidity through a systems biology approach

Preprint | 
10.55415/deep-2023-0035.v1
This is not the most recent version. There is anewer versionof this content available.
Chang Chen#
Department of Cardiology, Affiliated Hospital of Guilin Medical University, Guilin 541000, China
Department of Cardiology, Affiliated Hospital of Guilin Medical University, Guilin 541000, China
Ruping Cai#
Department of Rehabilitation Medicine, The Third Affiliated Hospital of Guangxi Medical University
Department of Rehabilitation Medicine, The Third Affiliated Hospital of Guangxi Medical University
Qiang Wu*
Department of Cardiology, the Sixth Medical Centre, Chinese PLA General Hospital, Beijing 100048, China, Journal of Geriatric Cardiology Editorial Office, Chinese PLA General Hospital, Beijing 100853, China
Department of Cardiology, the Sixth Medical Centre, Chinese PLA General Hospital, Beijing 100048, China, Journal of Geriatric Cardiology Editorial Office, Chinese PLA General Hospital, Beijing 100853, China
Qiang Su*
Department of Cardiology, Affiliated Hospital of Guilin Medical University, Guilin 541000, China
Department of Cardiology, Affiliated Hospital of Guilin Medical University, Guilin 541000, China

# contributed equally to this work, * Corresponding author


Abstract

Background: 

Cardiovascular diseases especially acute myocardial infarction are the leading cause of disability and death. Atherosclerosis is the pathological basis of AMI, and chronic inflammation can accelerate the process. Ulcerative colitis is a chronic inflammatory disease associated with immunity with possible risks contributing to AMI development. However, controversy continues to surround the relationship between these two diseases. The present study unravels the pathogenesis of AMI and UC, which may provide a new perspective on the clinical management of patients with these comorbidities.


Methods: 

Download microarray datasets GSE66360 and GSE87473 from gene expression omnibus database. Identification of common differentially expressed genes (co-DEGs) in AMI and UC followed, the following analysis was carried out: enrichment analysis, protein-protein interaction network construction, hub gene identified and co-expression analysis.

Results:

Totally 267 co-DEGs (233 upregulated and 34 downregulated) were screened for further analysis. GO enrichment analysis emphasizes the important role of chemokines and cytokines in these two diseases. In addition, lipopolysaccharide-mediated signaling pathway is closely related to both. KEGG enrichment analysis reveals that lipid and atherosclerosis, NF-κB, TNF and IL-17 signaling pathways are the core mechanisms involved in the progression of these two diseases. Finally, 11 hub genes were identified with cytoHubba, including TNF, IL1B, TLR2, CXCL8, STAT3, MMP9, ITGAX, CCL4, CSF1R, ICAM1, and CXCL1.

Conclusion:

This study reveals a co-pathogenesis mechanism of AMI and UC regulated for specific hub genes, which not only provides new ideas for further mechanistic studies, but also provides new perspectives on the clinical management of patients suffering from these comorbidities.

Keywords
Subject Area
Version History
  • 07 Jun 2023 15:45 Version 1
Scores
 0
Rapid Rating Times: 0
· Level of Quality: -
· Level of Repeatability: -
· Level of Innovation: -
· Level of Impact: -

*Each rating ranges from 0-5

Rapid Rating
Your professional field is different from the direction of this article. Go Settings!
  • Level of Quality
    Is the publication of relevance for the academic community and does it provide important insights? Is the language correct and easy to understand for an academic in the field? Are the figures well displayed and captions properly described? Is the article systematically and logically organized?
    0.0
  • Level of Repeatability
    Is the hypothesis clearly formulated? Is the argumentation stringent? Are the data sound, well-controlled and statistically significant? Is the interpretation balanced and supported by the data? Are appropriate and state-of-the-art methods used?
    0.0
  • Level of Innovation
    Does the work represent a novel approach or new findings in comparison with other publications in the field?
    0.0
  • Level of Impact
    Does the work have potential huge impact to the related research area?
    0.0
Submit

我们使用 cookie 将您与其他用户区分开来, 并在我们的网站上为您提供更好的体验。

关闭此消息以接受 cookie 或了解如何管理您的 cookie 设置。

了解更多关于我们的隐私声明..

goTop